ZYVERSA THERAPEUTICS

zyversa-therapeutics-logo

ZyVersa is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop first-in-class drugs. Our focus is on patients with inflammatory or renal diseases who have significant unmet medical needs. Our development pipeline includes a novel inflammasome inhibitor with potential to treat multiple inflammatory diseases, and phase 2a-ready VAR 200, a cholesterol efflux mediator for treatment of a rare kidney disease, focal segmental glomerulosclerosis (FSGS), with potential to treat other kidney diseases.
#SimilarOrganizations #People #Financial #Website #More

ZYVERSA THERAPEUTICS

Social Links:

linkedin

Linkedin

Industry:
Health Care Health Diagnostics Medical

Founded:
2014-01-01

Address:
Weston, Florida, United States

Country:
United States

Website Url:
http://www.zyversa.com

Total Employee:
11+

Status:
Active

Total Funding:
23.7 M USD

Technology used in webpage:
Amazon IPv6 Amazon S3 Akamai Hosted


Similar Organizations

clincierge-logo

Clincierge

Clincierge enables patients to connect more effectively with clinical trials of new medicines.

polycore-therapeutics-logo

PolyCore Therapeutics

PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.

sebela-pharmaceuticals-logo

Sebela Pharmaceuticals

Sebela is committed to improving patients’ lives by developing, marketing and selling differentiated branded prescription pharmaceuticals.

Current Employees Featured

karen-cashmere_image

Karen Cashmere
Karen Cashmere Chief Commercial Officer @ ZyVersa Therapeutics
Chief Commercial Officer
2019-01-01

shawn-titcomb_image

Shawn Titcomb
Shawn Titcomb Co-Founder and former Chairman @ ZyVersa Therapeutics
Co-Founder and former Chairman
2014-03-01

stephen-c-glover_image

Stephen C. Glover
Stephen C. Glover Co-Founder, Chairman & Chief Executive Officer @ ZyVersa Therapeutics
Co-Founder, Chairman & Chief Executive Officer
2014-03-01

Founder


shawn-titcomb_image

Shawn Titcomb

stephen-c-glover_image

Stephen C. Glover

Stock Details


Company's stock symbol is NASDAQ:ZVSA

Investors List

the-michael-j-fox-foundation_image

Michael J. Fox Foundation

Michael J. Fox Foundation investment in Grant - ZyVersa Therapeutics

Official Site Inspections

http://www.zyversa.com Semrush global rank: 6.29 M Semrush visits lastest month: 1.05 K

  • Host name: ec2-174-129-30-187.compute-1.amazonaws.com
  • IP address: 174.129.30.187
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "ZyVersa Therapeutics"

Management Team :: ZyVersa Therapeutics, Inc.

About ZyVersa. ZyVersa is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription …See details»

ZyVersa Therapeutics - Crunchbase Company Profile

Organization. ZyVersa Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»

Board of Directors :: ZyVersa Therapeutics, Inc.

Before founding ZyVersa, Mr. Glover was Co-Founder and CBO of Coherus Biosciences where he was focused on the business strategy, partnerships, product development efforts and …See details»

ZyVersa Therapeutics Inc. | LinkedIn

ZyVersa (Nasdaq: ZVSA) is a clinical stage specialty biopharmaceutical company leveraging two licensed proprietary product platforms to develop pharmaceutical products that address unmet medical ...See details»

Zyversa Therapeutics Inc (ZVSA-Q) Profile - The Globe and Mail

Apr 25, 2017 See the company profile for Zyversa Therapeutics Inc (ZVSA-Q) including business summary, industry/sector information, business summary, corporate governance, …See details»

ZyVersa Therapeutics, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for ZyVersa Therapeutics, Inc. of Weston, FL. Get the latest business insights from Dun & Bradstreet.See details»

ZyVersa Therapeutics - Contacts, Employees, Board Members

ZyVersa is committed to improving health outcomes and quality of life for patients with inflammatory and renal diseases. ... Experience the new Crunchbase, powered by AI . …See details»

ZyVersa Therapeutics - Overview, News & Similar companies

May 15, 2024 ZyVersa Therapeutics contact info: Phone number: (754) 231-1688 Website: www.zyversa.com What does ZyVersa Therapeutics do? ZyVersa is a clinical stage specialty …See details»

Investor Relations | ZyVersa Therapeutics, Inc.

ZyVersa is a clinical stage specialty biopharmaceutical company with two licensed proprietary product platforms invented by top tier research scientists at University of Miami Miller School …See details»

ZyVersa Therapeutics - Funding, Financials, Valuation & Investors

ZyVersa is committed to improving health outcomes and quality of life for patients with inflammatory and renal diseases. New. Resources. Advanced Search. ... How much funding …See details»

ZyVersa Therapeutics Inc.: Developing Innovative Drug Therapies …

ZyVersa Therapeutics, Inc. www.zyversa.com Contact: Stephen C. Glover 754-231-1690 [email protected] Interview conducted by: Lynn Fosse, Senior Editor CEOCFO Magazine …See details»

ZyVersa Therapeutics Inc. Information - RocketReach

ZyVersa (Nasdaq: ZVSA) is a clinical stage specialty biopharmaceutical company leveraging two licensed proprietary product platforms to develop pharmaceutical products that address unmet …See details»

ZyVersa Therapeutics CEO Issues Shareholder Letter on PARASOL ...

WESTON, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in …See details»

ZyVersa Therapeutics Reports Full Year 2024 Financial Results and ...

WESTON, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical-stage specialty biopharmaceutical company developing first-in …See details»

News Releases - ZyVersa Therapeutics, Inc.

Mar 27, 2025 WESTON, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA), a clinical-stage biopharmaceutical company specializing in first-in-class …See details»

About :: ZyVersa Therapeutics, Inc.

About ZyVersa. ZyVersa is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription …See details»

ZyVersa Therapeutics Announces Strategic Developments for

2 days ago ZyVersa (Nasdaq: ZVSA) is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop first-in-class drugs for patients with …See details»

ZyVersa Unveils Groundbreaking Potential of Inflammasome

2 days ago ZyVersa (Nasdaq: ZVSA) is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop first-in-class drugs for patients with …See details»

ZyVersa Therapeutics Highlights Review Article Supporting the …

WESTON, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in …See details»

WASHINGTON, D.C. 20549 SECURITIES AND EXCHANGE …

ZYVERSA THERAPEUTICS, INC. (E xa c t na m e of re gi s t ra nt a s s pe c i fi e d i n i t s c ha rt e r) D e l aw are. 86-2685744 (S t a t e . or ot he r j uri s di c t i on. of . i nc orpora t i on or orga …See details»

linkstock.net © 2022. All rights reserved